Navigation Links
Pharmacyclics Reports Third Quarter 2008 Financial Results
Date:4/24/2008

- Company to Host Conference Call at 4:30 p.m. EDT Today -

SUNNYVALE, Calif., April 24 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results for its third fiscal quarter ended March 31, 2008. The net loss for the third quarter of fiscal 2008 was $7.0 million, or $0.27 per share, compared to a net loss of $6.8 million, or $0.26 per share, in the third quarter of fiscal 2007.

Total operating expenses were $7.2 million in the third quarter of fiscal 2008 compared to $7.4 million for the third quarter of fiscal 2007, a decrease of $0.2 million. Share-based compensation expense was $0.5 million in the third quarter of fiscal 2008 compared to $0.9 in the third quarter of fiscal 2007. The decrease in total operating expenses in the third quarter of fiscal 2008 was primarily related to reduced personnel expenses due to lower headcount and lower share-based compensation expense, partially offset by increased outside pre-clinical and drug manufacturing expenses associated with the Company's HDAC, Btk and Factor VIIa inhibitor programs.

Pharmacyclics also reported its financial results for the nine months ended March 31, 2008. The net loss for the nine months ended March 31, 2008 was $19.7 million, or $0.76 per share, compared to a net loss of $19.2 million, or $0.82 per share, for the nine months ended March 31, 2007.

As of March 31, 2008 the company's cash, cash equivalents and marketable securities totaled $21.3 million compared to $38.8 million at June 30, 2007. The company expects cash used in operations over the next four quarters to be approximately $16 million.

"In the remainder of 2008, we anticipate expanding our clinical programs with our oral HDAC inhibitor,
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
2. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
3. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... 1 With employee benefit...f employers are providing self-service decision-ma...n, according to a new survey by Watson Wyatt, a le...ers who offer these tools believe they lead employ... According to the survey, 45 percent of companies ...
(Date:12/1/2009)...Dec. 1 On December 31, ...federal prisoners were HIV positive or had confirm... the Office of Justice Programs, U.S. Department o...timated 5,672 inmates in state and federal prisons...007, about 43 per 10,000 prison inmates were estim...
(Date:12/1/2009)... and South America, study finds , , TUES...f intensive care unit patients worldwide suffer in...e hospital, a new study finds. , Researchers an...) on 13,796 patients, aged 18 and older, in 1,265 ...f patients were classified as infected and 71 perc...
(Date:12/1/2009)...2009) Wistar Institute researchers and collaborat...rk University have identified immune system marker...ors in people at high risk for developing lung can... Cancer Research , a journal of the American Assoc... blood test to detect lung cancer in its earliest ...
(Date:12/1/2009)...GLE PARK, N.C., Dec. 1 Max Neeman ...expanded over the years serving the top most pharm...as originally set up in an area of 2000 sq. ft. ha...of the suite of services by Max Neeman, are recogn...ffering. ,, The pharmacy inventory management p...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3
...elieve they eat a lot of meat because of the taste...the Journal of Consumer Research, the reason tha... to some people has more to do with values than ac...r Food Industries and Management, France) conducte...
...called a primary stumbling block , , THURS...care in the United States continues to elude more ...ore, since the first "scorecard" was done in 2006,...on. , These are some of the findings in the Common...
...vest Products,Inc. (OTC Bulletin Board: FRHV.OB) a...its long standing commitment to providing consumer...ings, through a new initiative to,build natural an...lieve that this new initiative is a natural and lo...
... Digital Documents, a,provider of turnkey, cost-ef...d HCAHPS Surveys, announced today the integration ... Health Systems, the largest,not-for-profit Protes...e expensive," commented Bruce,Genger, President of...
...January 2, 2009 -, LAVAL, QC, July 17 /PRNewswire...SS) today announced that the response that it subm...A) on July 2, 2008, including the,additional analy...cription Drug User Fee Act (PDUFA) is January 2, 2...
...IGNA, the health service company, launched its new...ents in the Wall Street Journal. Supported by Dore...gn will be the largest in CIGNA's history, an... Philadelphia, PA (PRWEB) July 1...
Other Medicine News:Health News:Good news for veggies 2Health News:U.S. Health Care Still Ill, Survey Finds 2Health News:U.S. Health Care Still Ill, Survey Finds 3Health News:Fresh Harvest Products, Inc. Announces New Brand Initiative 2Health News:Innovative HCAHPS Patient Satisfaction Survey Solution Generates Huge Cost-Savings Opportunity for Adventist Health Systems 2Health News:FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response 2Health News:CIGNA Launches National "It's Time to Feel Better" Advertising Campaign to Support Health Service Mission 2Health News:CIGNA Launches National "It's Time to Feel Better" Advertising Campaign to Support Health Service Mission 3
(Date:12/1/2009)...c. 1 CCS Medical, Inc. a leading d...day announced that it has received approval from t...Delaware (the "Court") for its bidding procedures ... of substantially all of its assets. ,, Pursuan...pproved bidding procedures for the sale of substan...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasda...on, today announced the honorees of the 2009 WebMD...lth Heroes honor Americans with extraordinary stor... an effort to help others achieve better health. ...prnh/20091201/NY18114 ) ,, "WebMD is honoring ...
(Date:12/1/2009)..., Dec. 1 nContact Surgical, Inc. (...ces for minimally-invasive treatment for heart con...bility clinical trial designed to evaluate the saf...er procedure, the convergent procedure, for the tr...ion (AF). This prospective, feasibility study wil...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 1Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 1Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 2Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 3
...d in Third Quarter -, SAN FRANCISCO, March 20 VI...y company focused on the development of,compounds ...nced today that,it has completed patient enrollmen...irst of three Phase 2 trials investigating VIA-229...1 is a potent small molecule drug that targets inf...
... not the Only Way We Suffer - Allerg...N.J. and WHITEHOUSE STATION, N.J., March 20, Indoo...ople in the United States.(1)(2) Yet, according to... survey, allergies are often,disregarded as a nuis...ect.,As a result, allergy sufferers continue to co...
Other Medicine Technology:VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 7
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: